MEDICINSK AFDELING M

Forskningspublikationer

Monografier

Beck-Nielsen, H.; Flyvbjerg, A.: Håndbog om Type 2 diabetes . Diabetesforeningens Forlag: 1-185 pages, 2002.

Lund, S.: Studies of mechanisms involved in regulation of glucose transporter proteins in rat and human skeletal muscles . Fællestrykkeriet for Sundhedsvidenskab, Aarhus Universitet, 2002.

Mogensen, C.E.: Hypertension and Diabetes . Lippincott Williams & Wilkins: vol. 1 pages, 2002.

Nielsen, S.: Microalbuminuria in type 2 diabetes. Relationship with renal function, insulin resistance, and vascular dysfunction . Fællestrykkeriet for Sundhedsvidenskab, Aarhus Universitet, 2002.

Bidrag i antologier

Andersen, H.H.; Mogensen, C.E.: Combination therapy with candesartan and lisinopril in type 2 diabetes and hypertension: The Calm Study. In: Harrison's Medical Textbook Online edition . harrisons.accessmedicine.com. april. McGraw-Hill education, 2002.

Frystyk, J.; Flyvbjerg, A.: Measurement of IGF-I bioactivity in humans. In: The Expanding role of Octreotide . Lamberts, S.W.J.; Ghigo, E. (Eds.). BioScientifica, Woodlands, Bristol: pp. 225-234, 2002.

Jørgensen, J.O.L.; Hansen, T.K.; Conceicao, F.L.; Christiansen, J.J.; Kristiansen, M.T.; Vahl, N.; Christiansen, J.S.: Somatopause and body composition. In: Textbook of Men's Health : pp. 235-240, 2002.

Mogensen, C.E.: Concluding remarks. In: Clinicians Manual on Microalbuminuria . Mogensen, C.E. (Ed.). Science Press, London: pp. 51-57, 2002.

Mogensen, C.E.: Microalbuminuria in perspectives. In: Diabetic renal-retinal syndrome 2001 . Friedman, E.A.; L'Esperance, F.A. (Ed.). Kluwer Academic Publ, Dordrecth: pp. 105-120, 2002.

Mogensen, C.E.: Microalbuminuria: concepts and definition. In: Clinicians Manual on Microalbuminuria . Mogensen, C.E. (Ed.). Science Press, London: pp. 1-11, 2002.

Artikler i internationale tidsskrifter

Buhl, E.S.; Jessen, N.; Pold, R.; Ledet, T.; Flyvbjerg, A.; Pedersen, S.B.; Pedersen, O.; Schmitz, O.; Lund, S.: Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes 51(7): 2199-2206, 2002.

Christiansen, J.J.; Vahl, N.; Fisker, S.; Møller, N.; Christiansen, J.S.; Jørgensen, J.O.: Age dimorphism in the association between growth-hormone status and the respiratory quotient. Obes Res 10(4): 284-290, 2002.

Christiansen, J.S.; Vahl N.; Nørrelund H.; Jørgen­sen, J.O.: Effects of GH replacement in young patients with childhood onset GH deficiency. Int J Clin Pract 126(suppl. May): 32-36, 2002.

Dagnæs-Hansen, F.; Holst, H.U.; Søndergaard, M.; Vorup-Jensen, T.; Flyvbjerg, A.; Jensen, U.B.; Jensen, T.G.: Physiological effects of human growth hormone produced after hydrodyna­mic: gene transfer of a plasmid vector containing the human ubiquitin promotor. J Mol Med 80(10): 665-670, 2002.

Dall, R.; Kanaley J, Hansen, T.K.; Møller, N.; Christiansen, J.S.; Hosoda, H.; Kangawa, K.; Jørgensen, J.O.: Plasma ghrelin levels during exercise in healthy subjects and in growth hormone-deficient patients. Eur J Endocrinol 147(16): 65-70, 2002.

Djurhuus, C.B.; Gravholt, C.H.; Nielsen, S.; Mengel, A.; Christiansen, J.S.; Schmitz, O.E.; Møller, N.: Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans. Am J Physiol Endocrinol Metab 283(1): E172-E177, 2002.

Djurhuus, C.B.; Hansen, T.K.; Gravholt, C.; Ørskov, L.; Hosoda, H.; Kangawa, K.; Jørgensen, J.O.; Holst, J.J.; Schmitz, O.: Circulating levels of ghrelin and GLP-1 are inversely related during glucose ingestion. Horm Metab Res 34(7): 411-413, 2002.

Djurhuus, C.B.; Hansen, T.K.; Holst, J.J.; Schmitz, O.: Feast or famine - are GLP-1 and ghrelin secretion intertwined? Horm Metab Res 34(7): 353-354, 2002.

Ebbehøj, E.; Poulsen, P.L.; Hansen, K.W.; Knudsen, S.T.; Mølgaard, H.; Mogensen, C.E.: Effects on heart rate variability of metoprolol supplementary to ongoing ACE-inhibitor treatment in Type I diabetic patients with abnormal albuminuria. Diabetologia 45(7): 965-975, 2002.

Flyvbjerg, A.; Dagnæs-Hansen, F.; De Vriese, A.S.; Schrijvers, B.F.; Tilton, R.G.; Rasch, R.: Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 51(10): 3090-3094, 2002.

Flyvbjerg, A.; Schrijvers, B.F.; De Vriese, A.S.; Tilton, R.G.; Rasch, R.: Compensatory glomerular growth after unilateral nephrectomy is VEGF dependent. Am J Physiol Endocrinol Metab 283(2): E362-E366, 2002.

Foss, C.H.; Vestbo, E.; Frøland, A.; Ingerslev, J.; Gjessing, H.J.; Mogensen, C.E.; Damsgaard, E.M.: Insulin resistance is accompanied by increased von Willebrand factor levels in nondiabetic women: a study of offspring of type 2 diabetic subjects compared to offspring of nondiabetic subjects. J Intern Med 252(2): 155-163, 2002.

Frystyk, J.; Højlund, K.; Rasmussen, K.N.; Jørgensen, S.P.; Wildner-Christensen, M.; Ørskov, H.: Development and clinical evaluation of a novel immunoassay for the binary complex of IGF-I and IGF-binding protein-1 in human serum. J Clin Endocrinol Metab 87(1): 260-266, 2002.

Frystyk, J.; Ledet, T.; Møller, N.; Flyvbjerg, A.; Ørskov, H.: Cardiovascular disease and insulin-like growth factor I. Circulation 106(8): 893-895, 2002.

Frøbert, O.; Mikkelsen, E.O.; Bagger, J.P.; Gravholt, C.H.: Measurement of interstitial lactate during hypoxia-induced dilatation in isolated pressurised porcine coronary arteries. J Physiol 539(Pt 1): 277-284, 2002.

Gravholt, C.H.; Dall, R.; Christiansen, J.S.; Møller, N.; Schmitz O.: Preferential stimulation of abdominal subcutaneous lipolysis after prednisolone exposure in humans. Obes Res 10(8): 774-781, 2002.

Gravholt, C.H.; Lauridsen, A.L.; Brixen, K.; Mosekilde, L.; Heickendorff, L.;; Christiansen, J.S.: Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult turner syndrome: a cross-sectional study. J Clin Endocrinol Metab 87(6): 2798-2808, 2002.

Gravholt, C.H.; Næraa, R.W.; Andersson, A.M.; Christiansen, J.S.; Skakkebæk, N.E.: Inhibin A and B in adolescents and young adults with Turner's syndrome and no sign of spontaneous puberty. Hum Reprod 17(8): 2049-2053, 2002.

Gravholt, C.H.; Næraa, R.W.; Brixen, K.; Kastrup, K.W.; Mosekilde, L.; Jørgensen, J.O.; Christiansen, J.S.: Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study. Pediatrics 110(5): 889-896, 2002.

Gravholt, C.H.; Warburg, M.; Friedrich, U.: Mild Noonan phenotype associated with coloboma of the iris and choroid. Clin Dysmorphol 11(1): 75-77, 2002.

Greisen, S.; Flyvbjerg, A.; Ledet, T.; Ovesen P.: Regulation of insulin-like growth factor binding protein secretion by human granulosa luteal cells in a polycystic ovary-like environment. Fertil Steril 78(1): 162-168, 2002.

Grønbæk, H.; Nielsen, B.; Schrijvers, B.F.; Vogel, I.; Rasch, R.; Flyvbjerg, A.: Inhibition effect of octreotide on renal and glomerular growth in early experimental diabetes mice. J Endocrinol 172: 637-643, 2002.

Grønbæk, H.; Thøgersen, T.; Frystyk, J.; Vilstrup, H.; Flyvbjerg, A.; Dahlerup, J.F.: Low free and total insulinlike growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatment. Am J Gastroenterol 97(3): 673-678, 2002.

Hansen, T.K.: Pharmacokinetics and acute lipolytic actions of growth hormone. Impact of age, body composition, binding proteins, and other hormones. Growth Horm IGF Res 12(5): 342-358, 2002.

Hansen, T.K.; Dall, R.; Hosoda, H.; Kojima, M.; Kangawa, K.; Christiansen, J.S.; Jørgensen, J.O.: Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol (Oxf) 56(2): 203-206, 2002.

Hansen, T.K.; Fisker, S.; Hansen, B.; Sørensen, H.H.; Christiansen, J.S.; Jørgensen, J.O.; Ørskov, H.: Impact of GHBP interference on estimates of GH and GH pharmacokinetics. Clin Endocrinol (Oxf) 57(6): 779-786, 2002.

Hansen, T.K.; Gravholt, C.H.; Ørskov, H.; Ras­mussen, M.H.; Christiansen, J.S.; Jørgensen, J.O.: Dose dependency of the pharmaco­kinetics and acute lipolytic actions of growth hormone. J Clin Endocrinol Metab 87(10): 4691-4698, 2002.

Hansen, T.K.; Jørgensen, J.O.; Christiansen, J.S.: Body composition and circulating levels of insulin, insulin-like growth factor-binding protein-1 and growth hormone (GH)-binding protein affect the pharmacokinetics of GH in adults independently of age. J Clin Endocrinol Metab 87(5): 2185-2193, 2002.

Hollingdal, M.; Juhl, C.B.; Dall, R.; Sturis, J.; Veldhuis, J.D.; Schmitz, O.; Pørksen, N.: Glucocorticoid induced insulin resistance impairs basal but not glucose entrained high frequency insulin pulsatility in humans. Diabetologia 45(1): 49-55, 2002.

Jessen, N.; Pold, R.; Buhl, E.S.; Jensen, L.S.; Schmitz, O.; Lund, S.: Effects of AICAR and Exercise on Insulin-stimulated Glucose Uptake, Insulin Signaling and GLUT4 Content in Rat Skeletal Muscles. J Appl Physiol 20, 2002.

Juhl, C.; Grøfte, T.; Butler, P.C.; Veldhuis, J.D.; ­Schmitz, O.; Pørksen, N.: Effects of fasting on physiologically pulsatile insulin release in ­healthy humans. Diabetes 51(suppl. 1): S255-S257, 2002.

Juhl, C.B.; Hollingdal, M.; Sturis, J.; Jakobsen, G.; Agersø, H.; Veldhuis, J.; Pørksen, N.; Schmitz, O.: Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes. Diabetes 51(2): 424-429, 2002.

Jørgensen, J.O.L.; Nørrelund, H.; Conceicao, F.; Møller, N., Christiansen, J.S.: Somatotropin and glucose homeostasis: Considerations for patient management. Treat Endocrinol 1: 229-234, 2002.

Khamaisi, M.; Flyvbjerg, A.; Haramati, Z.; Raz, G.; Wexler, I.D.; Raz, I.: Effect of mild hypoinsulinemia on renal hypertrophy: growth hormone/insulin-like growth factor I system in mild streptozotocin diabetes. Int J Exp Diabetes Res 3(4): 257-264, 2002.

Knudsen, S.T.; Bek, T.; Poulsen, P.L.; Hove, M.N.; Rehling, M.; Mogensen, C.E.: Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathy. Diabetes Care 25(12): 2328-2334, 2002.

Knudsen, S.T.; Poulsen, P.L.; Hansen, K.W.; Ebbehøj, E.; Bek, T.; Mogensen, C.E.: Pulse pressure and diurnal blood pressure variation: association with micro- and macrovascular complications in type 2 diabetes. Am J Hypertens 15(3): 244-250, 2002.

Kristiansen, M.T.; Rasmussen, L.M.; Olsen, N.; Asa, S.L.; Jørgensen, J.O.: Ectopic ACTH syndrome: discrepancy between somatostatin receptor status in vivo and ex vivo, and between immunostaining and gene transcription for POMC and CRH. Horm Res 57(5-6): 200-204, 2002.

Kveiborg, M.; Flyvbjerg, A.; Kassem, M.: Synergistic effects of 1,25-Dihydroxyvitamin D3 and TGF-beta1 on the production of insulin-like growth factor binding protein 3 in human bone marrow stromal cell cultures. APMIS 110(5): 410-414, 2002.

Lange, K.H.; Larsson, B.; Flyvbjerg, A.; Dall, R.; Bennekou, M.; Rasmussen, M.H.; Ørskov, H.; Kjær, M.: Acute growth hormone administration causes exaggerated increases in plasma lactate and glycerol during moderate to high intensity bicycling in trained young men. J Clin Endocrinol Metab 87(11): 4966-4975, 2002.

Larsen, M.O.; Elander, M.; Sturis, J.; Wilken, M.; Carr, R.D.; Rolin, B.; Pørksen, N.: The conscious Gottingen minipig as a model for studying rapid pulsatile insulin secretion in vivo. Diabetologia 45(10): 1389-1396, 2002.

Legan, M.; Kocijancic, A.; Prezelj, J.; Osredkar, J.; Fisker, S.: GH-IGF-I axis in non-obese women with functional hyperandrogenism. J Endocrinol Invest 25(8): 691-695, 2002.

Mari, A.; Schmitz, O.; Gastaldelli, A, Østergaard, T.; Nyholm, B.; Ferrannini, E.: Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab 283(6): E1159-E1166, 2002.

Møller S.; Fisker, S.; Becker, U.; Henriksen, J.H.: Growth hormone binding protein in cirrhosis: normal or decreased? J Hepatol 37(5): 702-703, 2002.

Nielsen, S.; Mellemkjær, S.; Rasmussen, L.M.; Ledet, T.; Olsen, N.; Bojsen-Møller, M.; Astrup, J.; Weeke, J.; Jørgensen, J.O.: Expression of somatostatin receptors on human pituitary adenomas in vivo and ex vivo. J Endocrinol Invest 24(6): 430-437, 2002.

Nielsen, S.; Jørgensen, J.O.; Hartmund, T.; Nørrelund, H.; Nair, K.S, Christiansen, J.S.; Møller, N.: Effects of lowering circulating free fatty acid levels on protein metabolism in adult growth hormone deficient patients. Growth Horm IGF Res 12(6): 425-433, 2002.

Nielsen, S.; Møller, N.; Pedersen, S.B.; Christiansen, J.S.; Jørgensen, J.O.: The effect of long-term pharmacological antilipolysis on substrate metabolism in growth hormone (GH)-substituted GH-deficient adults. J Clin Endocrinol Metab 87(7): 3274-3278, 2002.

Nørrelund, H.; Hansen, T.K.; Ørskov, H.; Hosoda, H.; Kojima, M.; Kangawa, K.; Weeke, J.; Møller, N.; Christiansen, J.S.; Jørgensen, J.O.: Ghrelin immunoreactivity in human plasma is suppressed by somatostatin. Clin Endocrinol (Oxf) 57(4): 539-546, 2002.

Nørrelund, H.; Riis, A.L.; Møller, N.: Effects of GH on protein metabolism during dietary restriction in man. Growth Horm IGF Res 12(4): 198-207, 2002.

Ottesen, L.H.; Frystyk, J.; Kiszka-Kanowitz, M.; Grønbæk, H.; Bendtsen, F.; Flyvbjerg, A.: Effects of octreotide on serum insulin-like growth factor I and insulin-like growth factor binding proteins in patients with cirrhosis. Scand J Clin Lab Invest 62(16): 39-47, 2002.

Pedersen, S.B.; Lund, S.; Buhl, E.S, Richelsen, B.: Insulin and contraction directly stimulate UCP2 and UCP3 mRNA expression in rat. Biochem Biophys Res Commun 283(1): 19-25, 2002.

Poulsen, P.L.: Blood pressure and cardiac autonomic function in relation to risk factors and. J Renin Angiotensin Aldosterone Syst 3(4): 222-242, 2002.

Pørksen, N.; Grøfte, T.; Greisen, J.; Mengel, A.; Juhl, C.; Veldhuis, JD.; Schmitz, O.; Rossle, M.; Vilstrup, H.: Human insulin release processes measured by intraportal sampling. Am J Physiol Endocrinol Metab 282(3): E695-E702, 2002.

Raschke, M.; Wildemann, B.; Inden, P.; Bail, H.; Flyvbjerg, A.; Hoffmann, J.; Haas, N.P.; Schmidmaier, G.: Insulin-like growth factor-1 and transforming growth factor beta1 accelerates osteotomy healing using polylactide coated implants as a delivery system: a biomechanical and histological study in minipigs. Bone 30: 144-151, 2002.

Rasmussen, L.M.; Schmitz, O.; Ledet, T.: Increased expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured. Scand J Clin Lab Invest 62(7): 485-493, 2002.

Rosendal, L.; Langberg, H.; Flyvbjerg, A.; Frystyk, J.; Ørskov, H.; Kjær, M.: Physical capacity influences the response of insulin-like growth factor and its binding proteins to training. J Appl Physiol 93(5): 1669-1675, 2002.

Schmidmaier, G.; Wildemann, B.; Heeger, J.; Gabelein, T.; Flyvbjerg, A.; Bail, H.J.; Raschke, M.: Improvement of fracture healing by systemic administration of growth hormone and local application of insulin-like growth factor-1 and transforming growth factor-beta1. Bone 31(1): 165-172, 2002.

Schmitz, O.; Boison, G.; Salzmann, H.; Bothe, H.; Schutz, K.; Wang, SH.; Happe, T.: HoxE-a subunit specific for the pentameric bidirectional hydrogenase complex (HoxEFUYH) of cyanobacteria. Biochim Biophys Acta 1554(1-2): 66-74, 2002.

Schmitz, O.; Lund, S.; Andersen, P.H.; Jonler, M.; Pørksen, N.: Optimizing insulin secretagogue therapy in patients with type 2 diabetes: a randomized double-blind study with repaglinide. Diabetes Care 25(2): 342-346, 2002.

Schrijvers, B.F.; Rasch, R.; Tilton, R.G.; Flyvbjerg, A.: High protein-induced glomerular hyper­trophy is vascular endothelial growth factor-dependent. Kidney Int 61(5): 1600-1604, 2002.

Stoltenberg, M.; Flyvbjerg, A.; Søndergaard, L.G.; Rungby, J.: Decreased serum testosterone levels in rats exposed intraperitoneally to bismuth subnitrate. J Appl Toxicol 22(2): 111-115, 2002.

Stoving, R.K.; Andersen, M.; Flyvbjerg, A.; Frystyk, J.; Hangaard, J.; Vinten, J.; Koldkjær, O.G.; Hagen, C.: Indirect evidence for decreased hypothalamic somatostatinergic tone in anorexia nervosa. Clin Endocrinol (Oxf) 56(3): 391-396, 2002.

Thomsen, K.; Nielsen, C.B.; Flyvbjerg, A.: Effects of glycine on glomerular filtration rate and segmental tubular handling of sodium in conscious rats. Clin Exp Pharmacol Physiol 29(5-6): 449-454, 2002.

Ueland, T.; Ebbesen, E.N.; Thomsen, J.S.; Mosekilde, Li.; Brixen, K.; Flyvbjerg, A.; Bollerslev, J.: Decreased trabecular bone biochemical competence, apparent density, IGF-II and IFBP-5 content in acromegaly. Eur J Clin Invest 32: 122-128, 2002.

Ueland, T.; Bollerslev, J.; Flyvbjerg, A.; Hansen, T.B.; Vahl, N.; Mosekilde, L.: Effects of 12 months of GH treatment on cortical and trabecular bone content of IGFs and OPG in adults with acquired GH deficiency: a double-blind, randomized, placebo-controlled study. J Clin Endocrinol Metab 87(6): 2760-2763, 2002.

Vestergaard, H.; Lund, S.; Pedersen, O.: Rosiglitazone treatment of patients with extreme insulin resistance and diabetes mellitus due to insulin receptor mutations has no effects on glucose and lipid metabolism. J Intern Med 250(5): 406-414, 2002.

Vestergaard, P.; Jørgensen, J.O.; Hagen, C.; Hoeck, H.C.; Laurberg, P.; Rejnmark, L.; Brixen, K.; Weeke, J.; Andersen, M.; Conceicao, F.L.; Nielsen, T.L.; Mosekilde, L.: Fracture risk is increased in patients with GH deficiency or untreated prolactinomas-a case-control study. Clin Endocrinol (Oxf) 56(2): 159-167, 2002.

Vestergaard, P.; Lindholm, J.; Jørgensen, J.O.; Hagen, C.; Hoeck, H.C.; Laurberg, P.; Rejnmark, L.; Brixen, K.; Kristensen, L.O.; Feldt-Rasmussen, U.; Mosekilde, L.: Increased risk of osteoporotic fractures in patients with Cushing's syndrome. Eur J Endocrinol 146(1): 51-56, 2002.

Vestergaard, P.; Rejnmark, L.; Weeke, J.; Hoeck, H.C.; Nielsen, H.K.; Rungby, J.; Laurberg,; P.; Mosekilde, L.: Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism. Thyroid 12(1): 69-75, 2002.

Wills, V.L.; Gibson, K.; Karihaloot, C.; Jørgensen, J.O.: Complications of biliary T-tubes after choledochotomy. ANZ J Surg 72(3): 177-180, 2002.

Yakar, S.; Rosen, C.J.; Beamer, W.G.; Ackert-Bicknell, C.L.; Wu, Y.; Liu, J.L.; Ooi, G.T.; Setser, J.; Frystyk, J.; Boisclair, Y.R.; LeRoith, D.: Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110(6): 771-781, 2002.

van Neck, J.W.; Cingel, V.; van Vliet, A.K.; Drop, S.L.; Flyvbjerg, A.: High-protein induced renal enlargement is growth hormone independent. Kidney Int 62(4): 1187-1195, 2002.

Artikler i danske tidsskrifter

Ejskjær, N.; Christiansen, J.S.: Seksuel dysfunktion ved diabetes mellitus. Ugeskr Laeger 164(41): 4789-4791, 2002.

Rye, K.; Weeke, J.; Møller, N.: [Scurvy and adrenal insufficiency]. Ugeskr Laeger 164(39): 4548-4549, 2002.

Østergaard, T.; Buhl, E.; Lund, S.A.; Schmitz, O.E.: [Insulin resistance and muscle fibers]. Ugeskr Laeger 164(16): 2152-2155, 2002.

Reviews, videnskabelige anmeldelser

Artikler i internationale tidsskrifter

Andersen, N.H.; Mogensen, C.E.: Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers: evidence for and against the combination in the treatment of hypertension and proteinuria. Curr Hypertens Rep 4(5): 394-402, 2002.

Gravholt, C.H.: Turner Syndrome and the heart: cardiovascular complications and treatment strategies. Am J Cardiovascular Drugs 2(6): 401-413, 2002.

Jørgensen, J.O.L.; Nørrelund, H.; Vahl, N.; Juul, A.; Skakkebæk, N.E.; Christiansen, J.S.: Continuation of growth hormone therapy versus placebo in transition-phase patients with growth hormone deficience: Impact on body composition, insulin sensitivity and thyroid function. J Pediatric Endocrinol Metab 15(1355-1360), 2002.

Mogensen, C.E.: Diabetic renal disease in patients with type 2 diabetes mellitus. New strategies for prevention and treatment. Treat Endocrinol 12: 3-11, 2002.

Mogensen, C.E.: The reno-protective role of AT(1)-receptor blockers. J Hum Hypertens 16(suppl. 3): S52-S58, 2002.

Mogensen, C.E.; Zimmet, P.: Introduction. Diabetes/Metab Res Rev 18: S1-S2, 2002.

Pørksen, N.: The in vivo regulation of pulsatile insulin secretion. Diabetologia 45(1): 3-20, 2002.

Pørksen, N.; Hollingdal, M.; Juhl, C.; Butler, P.; Veldhuis, JD.; Schmitz, O.: Pulsatile insulin secretion: detection, regulation, and role in diabetes. Diabetes 51(suppl. 1): S245-S254, 2002.

Simpson, H.; Savine, R.; Sonksen, P.; Bengtsson, B.A.; Carlsson, L.; Christiansen, J.S.; Clemmons, D.; Cohen, P.; Hintz, R.; Ho, K.; Mullis, P.; Robinson, I.; Strasburger, C.; Tanaka, T.; Thorner, M.: Growth hormone replacement therapy for adults: into the new millennium. Growth Horm IGF Res 12(1): 1-33, 2002.

Wachtell, K.; Olsen, M.H.; Dahlöf, B.; Devereux, R.B.; Kjeldsen, S.E.; Nieminen, M.S.; Okin, P.M.; Papademetriou, V.; Mogensen, C.E.; Borch-Johnsen, K.; Ibsen, H.: Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study. J Hypertens 20: 405-412, 2002.

Wachtell, K.; Palmieri, V.; Olsen, M.H.; Bella, J.N.; Aalto, T.; Dahlöf, B.; Gerdts, E.; Wright, J.T.jr.; Papademetriou, V.; Mogensen, C.E.; Borch-Johnsen, K.; Ibsen, H.; Devereux, R.B.: Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function inhypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study. Am Heart J 143: 319-326, 2002.

Artikler i danske tidsskrifter

Laursen, T.; Jørgensen, J.O.L.; Christiansen, J.S.: Aktuelle og potentielle indikationer for behandling med væksthormon (GH). Medicus 4(2): 7-9, 2002.

Letters, kommentarer, videnskabelig debat

Artikler i internationale tidsskrifter

Parving, H.H.; Chaturvedi, N.; Viberti, G.C.; Mogensen, C.E.: Does microalbuminuria predict diabetic nephropathy? Diabetes Care 25: 406-407, 2002.

Riis, A.L.; Gravholt, C.H.; Djurhuus, C.B.; Nørrelund, H.; Jørgensen, J.O.; Weeke, J.; Møller, N.: Elevated regional lipolysis in hyperthyroidism. J Clin Endocrinol Metab 87(10): 4747-4753, 2002.

Artikler i danske tidsskrifter Hansen, K.W.; Poulsen, P.L.: [Adrenal insufficiency after unilateral adrenalectomy]. Ugeskr Laeger 164(18): 2420, 2002.

Poulsen, P.L.; Møller, N.; Schmitz, O.; Mogensen CE.: [Coffee and diabetes - something to be really concerned about?]. Ugeskr Laeger 164(21): 2783, 2002.